Cross-sectional comparison of first-generation antipsychotic long-acting injections vs risperidone long-acting injection: patient-rated attitudes, satisfaction and tolerability | Zendy

Sourabh Moti Singh | Zendy; Peter Haddad | Zendy; Nusrat Husain | Zendy; Eamonn Heaney | Zendy; Barbara Tomenson | Zendy; Imran B. Chaudhry | Zendy

Open Access

Cross-sectional comparison of first-generation antipsychotic long-acting injections vs risperidone long-acting injection: patient-rated attitudes, satisfaction and tolerability

Author(s) -

Sourabh Moti Singh,

Peter Haddad,

Nusrat Husain,

Eamonn Heaney,

Barbara Tomenson,

Imran B. Chaudhry

Publication year - 2016

Publication title -

therapeutic advances in psychopharmacology

Language(s) - English

Resource type - Journals

eISSN - 2045-1261

pISSN - 2045-1253

DOI - 10.1177/2045125316632458

Subject(s) - tolerability , risperidone , medicine , antipsychotic , patient satisfaction , psychiatry , medication adherence , adverse effect , schizophrenia (object oriented programming) , surgery

The objective of this study was to compare patients' attitudes and satisfaction with medication and patient-rated tolerability between those prescribed a first-generation antipsychotic long-acting injection (FGA-LAI) and those prescribed risperidone long-acting injection (RLAI).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research